Experimental Design and Analytics for Customized High Throughput Ligand Screening in Developing Affinity Purification Solutions

Speakers
  • Scientist, Avitide
    Biography
      I am a passionate and dedicated researcher with expertise in protein biochemistry and information technology. My training as an engineer and my tenacity to find solutions to problems align perfectly with my goal to improve the quality of human life through better and affordable drugs and healthcare. My experience as a software professional has allowed me to work with multiple teams and successfully develop & support enterprise level applications in a variety of programming languages. My skills as a quick learner, detailed oriented nature and ability to engage with large teams was highlighted by company-wide recognition for excellence in our project executions and client satisfaction. In my doctoral research, I developed highly reliable methods to improve protein stability (manuscripts in preparation). I have thrived on harnessing my engineering background and excellent communication skills in the discovery process and award-winning scientific presentations. I have demonstrated my project management skills in and outside the lab, with contributions to lab operations (managing resources for >20 person lab), recognition for mentoring undergraduate students (>800 students taught, with nominations for teaching excellence) and setting up successful interdisciplinary collaborations on research projects. The convergence of my passion, training and skills lies in an industrial setting, where I believe my expertise and enthusiasm will lead me to make an impact in healthcare through unwavering dedication and synergy. I care deeply about science education, play the drums, and enjoy travelling & the outdoors.

    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    SEP 27, 2019 9:00 AM PDT
    C.E. CREDITS
    SEP 27, 2019 9:00 AM PDT
    DATE: September 27, 2019TIME: 9:00am PT, 12:00pm ET Thienopyrazole derivatives have recently emerged as effective antitumoral agents with kinase inhibitory activity. In this s...
    OCT 31, 2019 9:00 AM PDT
    C.E. CREDITS
    OCT 31, 2019 9:00 AM PDT
    DATE: October 31, 2019TIME: 9:00am PDT, 12:00pm EDT INTRODUCTION: A major limitation for the development of 3D engineered tissues is the absence of viable and perfusable...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds